Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -856 | -3,251 | -2,490 | -1,739 | -866 |
| Depreciation Amortization | 71 | 261 | 188 | 117 | 49 |
| Other Working Capital | -51 | -58 | -213 | -256 | -252 |
| Other Operating Activity | 96 | -386 | -386 | -304 | -213 |
| Operating Cash Flow | $-740 | $-3,434 | $-2,900 | $-2,181 | $-1,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4 | -666 | -666 | -661 | -562 |
| Other Investing Activity | 0 | 0 | -2 | 0 | 0 |
| Investing Cash Flow | $4 | $-666 | $-668 | $-661 | $-562 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 615 | 615 | 556 |
| Debt Issued | N/A | 615 | N/A | N/A | N/A |
| Debt Repayment | N/A | -615 | N/A | N/A | N/A |
| Common Stock Issued | 524 | 1,372 | 231 | 290 | 3 |
| Other Financing Activity | 0 | 0 | -94 | -47 | 0 |
| Financing Cash Flow | $524 | $1,372 | $752 | $859 | $559 |
| Beginning Cash Position | 938 | 3,666 | 3,666 | 3,666 | 3,666 |
| End Cash Position | 726 | 938 | 852 | 1,682 | 2,381 |
| Net Cash Flow | $-212 | $-2,729 | $-2,815 | $-1,984 | $-1,285 |
| Free Cash Flow | |||||
| Operating Cash Flow | -740 | -3,434 | -2,900 | -2,181 | -1,283 |
| Capital Expenditure | -2 | -666 | -666 | -661 | -562 |
| Free Cash Flow | -742 | -4,101 | -3,567 | -2,843 | -1,844 |